Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27145460)

Published in Oncotarget on June 07, 2016

Authors

Xingming Chen1,2, Erich M Sturgis2,3, Chengyuan Wang1,4, Xiaoli Cao1,5, Yuncheng Li1,6, Qingyi Wei7, Guojun Li2,3

Author Affiliations

1: Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
2: Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
3: Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
4: Department of Otolaryngology-Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China.
5: Department of Ultrasound, Yantai Yuhuangding Hospital, Yantai, 264000, China.
6: Department of Otolaryngology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
7: Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.

Articles cited by this

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

The functions of animal microRNAs. Nature (2004) 64.85

Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47

MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29

miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43

Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol (2008) 12.35

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet (2006) 8.37

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97

HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol (2010) 6.53

Head and neck cancer. N Engl J Med (1993) 6.33

Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2008) 5.29

MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One (2007) 3.96

Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest (2008) 3.53

MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol (2008) 3.32

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer (2007) 3.24

Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat (2009) 2.60

microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res (2009) 2.51

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res (2007) 2.48

The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc (2008) 2.21

microRNAs and the immune response. Curr Opin Pharmacol (2009) 2.18

Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer (2009) 1.98

MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68

Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res (2010) 1.44

Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.14

Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. Cancer (2009) 1.09

Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. Clin Cancer Res (2012) 1.05

Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res (2010) 0.99

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg (2012) 0.99

Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Cancer Lett (2012) 0.96

MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients. PLoS One (2013) 0.88

Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Ann Oncol (2013) 0.88

Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy. Int J Cancer (2013) 0.87

Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population. DNA Cell Biol (2012) 0.83

Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy. Int J Cancer (2015) 0.83

Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx. Int J Cancer (2013) 0.82

Update of assessment of survival in head and neck cancer after regional recurrence. J Oncol (2012) 0.82

miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients. Tumour Biol (2016) 0.76